M A7
Pill imprint M A7 has been identified as Alendronate sodium 10 mg.
Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy.
Alendronate 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Alendronate sodium Images
- Imprint:
-
M
A7 - Strength:
- 10 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
sodium lauryl sulfate
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3567
More Alendronate Sodium resources
- Alendronate (Wolters Kluwer)
- Alendronate Solution (Wolters Kluwer)
- alendronate (Cerner Multum)
- alendronate (Micromedex) - Includes Dosage Information
- Alendronate Sodium (AHFS DI)
- Alendronate (FDA)
- Alendronate Sodium (Wolters Kluwer)


